These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20971510)

  • 1. The Myelodysplastic Syndromes (MDS) Foundation: a retrospective analysis of a nonprofit foundation.
    Bennett JM; Hamblin TJ; Mufti GJ
    Leuk Res; 2011 Mar; 35(3):283-5. PubMed ID: 20971510
    [No Abstract]   [Full Text] [Related]  

  • 2. Aplastic anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2010.
    Malcovati L; de Latour RP; Risitano A
    Leuk Res; 2011 Mar; 35(3):291-4. PubMed ID: 21036397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington state, 2005-2006.
    De Roos AJ; Deeg HJ; Onstad L; Kopecky KJ; Bowles EJ; Yong M; Fryzek J; Davis S
    Am J Hematol; 2010 Oct; 85(10):765-70. PubMed ID: 20815079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What to improve in approach to diagnose and treat pediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia in Poland?].
    Wójcik D; Pietras W; Ussowicz M; Chybicka A
    Przegl Lek; 2006; 63(1):29-30. PubMed ID: 16892896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment strategies in myelodysplastic syndromes.
    Atallah E; Garcia-Manero G
    Cancer Invest; 2008 Mar; 26(2):208-16. PubMed ID: 18259954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical aspect of myelodysplastic syndromes (MDS)].
    Hotta T
    Nihon Naika Gakkai Zasshi; 2000 Mar; 89(3):550-3. PubMed ID: 10804628
    [No Abstract]   [Full Text] [Related]  

  • 7. Myelodysplastic syndromes in childhood and adolescence: clinical and hematological profile.
    Singh ZN; Kashyap R; Pati HP; Choudhry VP
    Indian Pediatr; 2001 Jan; 38(1):72-6. PubMed ID: 11175937
    [No Abstract]   [Full Text] [Related]  

  • 8. The myelodysplastic syndromes.
    Nguyen PL
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):675-91. PubMed ID: 19577164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myelodysplastic syndromes].
    Paladini G; Pecorari P; De Sabbata G; Sammartini C
    Recenti Prog Med; 2004 Feb; 95(2):108-19. PubMed ID: 15072397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelodysplastic syndromes: aspects of current medical care and economic considerations in Germany.
    Gattermann N; Hofmann WK; Meessen A; Schmitz S; Tsamaloukas A; Vollmer T; Wedding U; Plesnila-Frank C; Schramm W; Berger K
    Onkologie; 2008 Sep; 31(8-9):477-84. PubMed ID: 18787357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndromes.
    Cilloni D; Messa F; Carturan S; Arruga F; Defilippi I; Messa E; Gottardi E; Saglio G
    Ann N Y Acad Sci; 2004 Dec; 1028():400-8. PubMed ID: 15650265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndromes: a practical approach to diagnosis and treatment.
    Barzi A; Sekeres MA
    Cleve Clin J Med; 2010 Jan; 77(1):37-44. PubMed ID: 20048028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric myelodysplastic syndromes.
    Rytting ME
    Curr Hematol Rep; 2004 May; 3(3):173-7. PubMed ID: 15087064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 59-year-old man with MDS.
    Deeg HJ
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):1001-2. PubMed ID: 19589492
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
    Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
    Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latency of onset of de novo myelodysplastic syndromes.
    Wu PS; Hay AE; Thomas GE; Bowen DT
    Haematologica; 2004 Nov; 89(11):1392-4. PubMed ID: 15531463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based study of survival in patients with secondary myelodysplastic syndromes (MDS): impact of type and treatment of primary cancers.
    De Roos AJ; Deeg HJ; Davis S
    Cancer Causes Control; 2007 Dec; 18(10):1199-208. PubMed ID: 17823848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference.
    Valent P; Horny HP; Bennett JM; Fonatsch C; Germing U; Greenberg P; Haferlach T; Haase D; Kolb HJ; Krieger O; Loken M; van de Loosdrecht A; Ogata K; Orfao A; Pfeilstöcker M; Rüter B; Sperr WR; Stauder R; Wells DA
    Leuk Res; 2007 Jun; 31(6):727-36. PubMed ID: 17257673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelodysplastic syndromes in the adolescent.
    Winter SS; Mathew P; Vaughan RL; Foucar K
    Adolesc Med; 1999 Oct; 10(3):401-6, x. PubMed ID: 10611937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prognostic value of a modified WPSS based on routine laboratory parameters in patients with myelodysplastic syndromes: a preliminary result].
    Li L; Nie L; Yu MH; Yu Y; Liu L; Qin TJ; Xu ZF; Zhang Y; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):313-7. PubMed ID: 19799126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.